"An Open-Label, Multinational, Multicenter, Phase IIIB Study With Subcutaneus Administration Of Trastuzumab In Patient With Her2-Positive Early Breast Cancer To Evaluate Patient Satisfaction"
2020-07-04
عنوان الدراسة
"An Open-Label, Multinational, Multicenter, Phase IIIB Study With Subcutaneus Administration Of Trastuzumab In Patient With Her2-Positive Early Breast Cancer To Evaluate Patient Satisfaction"
داعم الدراسة
Roche
دواء الدراسة
Trastuzumab SC
رقم بروتوكول الدراسة
ML28851
حالة الدراسة
Ongoing
موقع الدراسة
King Khalid University Hospital (Riyadh), International Medical Center (Jeddah)
مرحلة الدراسة
3b
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。